2022 Q4 Form 10-Q Financial Statement

#000168316822007604 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $2.342M $2.017M $1.454M
YoY Change 40.16% 38.74% -35.09%
Cost Of Revenue $1.102M $1.404M $865.5K
YoY Change 32.75% 62.25% -24.58%
Gross Profit $1.240M $613.1K $588.6K
YoY Change 47.49% 4.17% -46.12%
Gross Profit Margin 52.94% 30.39% 40.48%
Selling, General & Admin $1.025M $1.026M $1.201M
YoY Change 10.51% -14.54% -20.96%
% of Gross Profit 82.66% 167.36% 203.99%
Research & Development $271.6K $272.1K $268.9K
YoY Change 7.26% 1.2% 16.37%
% of Gross Profit 21.91% 44.39% 45.69%
Depreciation & Amortization $12.70K $8.702K $10.35K
YoY Change 33.26% -15.92% -29.4%
% of Gross Profit 1.02% 1.42% 1.76%
Operating Expenses $1.309M $1.307M $1.480M
YoY Change 10.0% -11.69% -16.14%
Operating Profit -$69.30K -$693.8K -$891.3K
YoY Change -80.17% -22.16% 32.56%
Interest Expense -$1.600K -$2.740K -$7.580K
YoY Change -10.11% -63.85% 72.67%
% of Operating Profit
Other Income/Expense, Net -$2.805K $908.5K
YoY Change -100.31%
Pretax Income -$70.90K -$696.6K $17.24K
YoY Change -79.81% -4140.6% -102.55%
Income Tax $7.680K $968.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$78.58K -$697.6K $17.24K
YoY Change -78.0% -4146.24% -102.55%
Net Earnings / Revenue -3.36% -34.58% 1.19%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $126.50
COMMON SHARES
Basic Shares Outstanding 299.2M shares 299.2M shares 136.3M shares
Diluted Shares Outstanding 299.2M shares 136.3M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.244M $3.721M $2.613M
YoY Change 37.38% 42.4% -8.6%
Cash & Equivalents $3.244M $3.721M $2.613M
Short-Term Investments
Other Short-Term Assets $702.5K $316.8K $617.1K
YoY Change -4.43% -48.67% 149.09%
Inventory $1.306M $1.408M $854.6K
Prepaid Expenses $702.5K $316.8K
Receivables $1.958M $1.940M $1.040M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.305M $7.413M $5.125M
YoY Change 40.53% 44.65% -18.51%
LONG-TERM ASSETS
Property, Plant & Equipment $126.1K $137.9K $707.5K
YoY Change 49.76% -80.51% -23.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $447.5K $479.4K $7.000K
YoY Change -22.59% 6748.94% -80.01%
Total Long-Term Assets $573.6K $617.3K $714.5K
YoY Change -13.39% -13.6% -25.14%
TOTAL ASSETS
Total Short-Term Assets $7.305M $7.413M $5.125M
Total Long-Term Assets $573.6K $617.3K $714.5K
Total Assets $7.879M $8.031M $5.839M
YoY Change 34.44% 37.53% -19.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.146M $628.6K $1.128M
YoY Change -38.59% -44.26% -5.59%
Accrued Expenses $702.6K $898.5K $997.4K
YoY Change -2.25% -9.91% 0.54%
Deferred Revenue $650.3K $940.1K
YoY Change -18.81%
Short-Term Debt $0.00 $0.00 $266.3K
YoY Change -100.0% -100.0% -72.78%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.662M $2.624M $3.530M
YoY Change -33.26% -25.67% -7.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $619.9K $726.0K $1.042M
YoY Change -35.42% -30.35% -14.81%
Total Long-Term Liabilities $619.9K $726.0K $1.042M
YoY Change -35.42% -30.35% -14.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.662M $2.624M $3.530M
Total Long-Term Liabilities $619.9K $726.0K $1.042M
Total Liabilities $3.282M $3.350M $4.572M
YoY Change -33.68% -26.73% -9.59%
SHAREHOLDERS EQUITY
Retained Earnings -$130.0M -$129.9M
YoY Change 1.0%
Common Stock $299.2K $299.2K
YoY Change 119.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.597M $4.681M $1.267M
YoY Change
Total Liabilities & Shareholders Equity $7.879M $8.031M $5.839M
YoY Change 34.44% 37.53% -19.38%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$78.58K -$697.6K $17.24K
YoY Change -78.0% -4146.24% -102.55%
Depreciation, Depletion And Amortization $12.70K $8.702K $10.35K
YoY Change 33.26% -15.92% -29.4%
Cash From Operating Activities -$476.5K -$612.1K -$558.0K
YoY Change 22.55% 9.7% 81.38%
INVESTING ACTIVITIES
Capital Expenditures $920.00 -$86.63K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.300K
YoY Change
Cash From Investing Activities -$920.00 -$85.33K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -546.0K -83.70K
YoY Change -100.0% 552.37% -228.16%
NET CHANGE
Cash From Operating Activities -476.5K -612.1K -558.0K
Cash From Investing Activities -920.0 -85.33K
Cash From Financing Activities 0.000 -546.0K -83.70K
Net Change In Cash -477.4K -1.243M -641.7K
YoY Change 89.43% 93.77% 164.81%
FREE CASH FLOW
Cash From Operating Activities -$476.5K -$612.1K -$558.0K
Capital Expenditures $920.00 -$86.63K
Free Cash Flow -$477.4K -$525.5K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001094084
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31972
dei Entity Registrant Name
EntityRegistrantName
TELKONET, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0627421
dei Entity Address Address Line1
EntityAddressAddressLine1
20800 Swenson Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 175
dei Entity Address City Or Town
EntityAddressCityOrTown
Waukesha
dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
53186
dei City Area Code
CityAreaCode
(414)
dei Local Phone Number
LocalPhoneNumber
302-2299
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
299212282 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3721024 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2361059 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1939676 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1010554 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1408442 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
825559 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
27579 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
266014 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
316754 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
735092 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
7413475 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
5198278 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
137879 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84201 usd
CY2022Q3 us-gaap Deposits Assets
DepositsAssets
4595 usd
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
7595 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
474831 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
570512 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
479426 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
578107 usd
CY2022Q3 us-gaap Assets
Assets
8030780 usd
CY2021Q4 us-gaap Assets
Assets
5860586 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
628604 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1865535 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
898538 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
718721 usd
CY2022Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
403089 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
940056 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
800965 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
153276 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
195176 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
3599 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5431 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2624073 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3988917 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
391680 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
459668 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
79301 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
140265 usd
CY2022Q3 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
255000 usd
CY2021Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
360000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
725981 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
959933 usd
CY2022Q3 us-gaap Liabilities
Liabilities
3350054 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4948850 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
475000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
475000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
299212282 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
299212282 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
136311335 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136311335 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
299212 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
136311 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
132583520 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
127740976 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129874830 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128668176 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
4680726 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
911736 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8030780 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5860586 usd
CY2022Q3 us-gaap Revenues
Revenues
2017334 usd
CY2021Q3 us-gaap Revenues
Revenues
1454068 usd
us-gaap Revenues
Revenues
6106409 usd
us-gaap Revenues
Revenues
4603766 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1404264 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
865519 usd
us-gaap Cost Of Revenue
CostOfRevenue
3143075 usd
us-gaap Cost Of Revenue
CostOfRevenue
2201454 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
613070 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
588549 usd
us-gaap Gross Profit
GrossProfit
2963334 usd
us-gaap Gross Profit
GrossProfit
2402312 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
272144 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
268917 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
798913 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
876778 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1026023 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1200569 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3310127 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3362761 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8702 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10346 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31129 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33935 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1306869 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1479832 usd
us-gaap Operating Expenses
OperatingExpenses
4140169 usd
us-gaap Operating Expenses
OperatingExpenses
4273474 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-693799 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-891283 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1176835 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1871162 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
916107 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1836780 usd
CY2022Q3 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-70 usd
CY2021Q3 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-526 usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2735 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7584 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21940 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-19286 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2805 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
908523 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22466 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1817494 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-696604 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
17240 usd
us-gaap Profit Loss
ProfitLoss
-1199301 usd
us-gaap Profit Loss
ProfitLoss
-53668 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
968 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7353 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1948 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-697572 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17240 usd
us-gaap Net Income Loss
NetIncomeLoss
-1206654 usd
us-gaap Net Income Loss
NetIncomeLoss
-55616 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
299212282 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136311335 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
295592261 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136311335 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
299212282 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136311335 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295592261 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136311335 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1317259 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1815 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
82739 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1401813 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1816 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-155595 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1248034 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1815 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17240 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1267089 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
911736 usd
CY2022Q1 TKOI Stock And Warrants Issued In Vda Transaction
StockAndWarrantsIssuedInVdaTransaction
5000000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
29801 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1815 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-517828 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5365922 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1815 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8746 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
5376483 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1815 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-697572 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
4680726 usd
us-gaap Net Income Loss
NetIncomeLoss
-1206654 usd
us-gaap Net Income Loss
NetIncomeLoss
-55616 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5445 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5446 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31129 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33935 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-526 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-0 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
95681 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
172161 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-0 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
1836780 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
929122 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6758 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
582883 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-533648 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-418338 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
474370 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-3000 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-0 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1236931 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
84733 usd
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-105000 usd
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-105000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
179817 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
235124 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
78127 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
232825 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-238435 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
76772 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-109888 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-180134 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-1832 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
7509 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-0 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-105745 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3121812 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1310788 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
86633 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1300 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-85333 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
913063 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5000000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
29801 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
-0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4434152 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
5357000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4837241 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5357996 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4567110 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
912067 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1359965 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-398721 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2361059 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3011811 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3721024 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2613090 usd
us-gaap Interest Paid Net
InterestPaidNet
21940 usd
us-gaap Interest Paid Net
InterestPaidNet
18643 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zDDi5BEbobHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_866_zPt0waB9thWb">Critical Accounting Policies and Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. On an ongoing basis, the Company evaluates significant estimates used in preparing its consolidated financial statements including those related to revenue recognition and allowances for uncollectible accounts receivable, inventory obsolescence, recovery of long-lived assets, income tax provisions and related valuation allowance, stock-based compensation, and contingencies. The Company bases its estimates on historical experience, underlying run rates and various other assumptions that the Company believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates. The following critical judgments, assumptions, and estimates used in the preparation of the consolidated financial statements are summarized below. Please refer to our most recent Form 10-K filed with the SEC for a more in-depth analysis of such policies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
2751 usd
us-gaap Advertising Expense
AdvertisingExpense
3402 usd
us-gaap Advertising Expense
AdvertisingExpense
5725 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
272144 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
268917 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
798913 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
876778 usd
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p id="xdx_844_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zOQlkM18EWuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_863_zKcBT054UfUd">Guarantees and Product Warranties</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company records a liability for potential warranty claims. The amount of the liability is based on the trend in the historical ratio of claims to sales. The products sold are generally covered by a warranty for a period of one year. In the event the Company determines that its current or future product repair and replacement costs exceed its estimates, an adjustment to these reserves would be charged to earnings in the period such determination is made. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Product warranties for the nine months ended September 30, 2022 and the year ended December 31, 2021 are as follows:  </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zssHVwk9n8D8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details-Product warranties)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zJ4jPpVZx9Uf" style="display: none">Schedule of product warranty accrual</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20220101__20220930_zbQdyKsp8Iif" style="width: 13%; text-align: right" title="Beginning balance">46,650</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20210101__20211231_zOV4z081FWlc" style="width: 13%; text-align: right" title="Beginning balance">45,328</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warranty claims incurred</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ProductWarrantyAccrualWarrantieIssued_c20220101__20220930_pp0p0" style="text-align: right" title="Warranty claims incurred">(5,296</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ProductWarrantyAccrualWarrantieIssued_c20210101__20211231_pp0p0" style="text-align: right" title="Warranty claims incurred">(16,075</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Provision charged (credited) to expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_c20220101__20220930_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Provision charged (credited) to expense">(770</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Provision charged (credited) to expense">17,397</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20220101__20220930_zw3RBhvjyrB" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">40,584</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20210101__20211231_zs3YtOh8VlF" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">46,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zY7JK3g7KJD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
46650 usd
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
45328 usd
TKOI Product Warranty Accrual Warrantie Issued
ProductWarrantyAccrualWarrantieIssued
-5296 usd
CY2021 TKOI Product Warranty Accrual Warrantie Issued
ProductWarrantyAccrualWarrantieIssued
-16075 usd
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-770 usd
CY2021 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
17397 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
40584 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
46650 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295592261 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136311335 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-697572 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17240 usd
us-gaap Net Income Loss
NetIncomeLoss
-1206654 usd
us-gaap Net Income Loss
NetIncomeLoss
-55616 usd
CY2022Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
23505 usd
CY2021Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
23505 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
69743 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
69743 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-721077 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6265 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1276397 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-125359 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
299212282 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136311335 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
295592261 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136311335 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
299212282 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136311335 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zAurXScxaCoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_860_zlZ1uCyp1c8g">Concentrations of Credit Risk</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with quality credit institutions. At times, such investments may be in excess of the FDIC insurance limit. The Company has never experienced any losses related to these balances. With respect to trade receivables, the Company performs ongoing credit evaluations of its customers’ financial conditions and limits the amount of credit extended when deemed necessary. The Company provides credit to its customers primarily in the United States in the normal course of business. The Company routinely assesses the financial strength of its customers and, as a consequence, believes its trade receivables credit risk exposure is limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q3 us-gaap Revenues
Revenues
2017334 usd
us-gaap Revenues
Revenues
6106409 usd
CY2021Q3 us-gaap Revenues
Revenues
1454068 usd
us-gaap Revenues
Revenues
4603766 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
700000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1 pure
CY2022Q3 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
27579 usd
CY2021Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
266014 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
940056 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
800965 usd
CY2022Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2001844 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1016117 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
62168 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
5563 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1939676 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1010554 usd
CY2022Q3 TKOI Accrued Inventory In Transit
AccruedInventoryInTransit
157263 usd
CY2021Q4 TKOI Accrued Inventory In Transit
AccruedInventoryInTransit
0 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
118453 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
136584 usd
CY2022Q3 us-gaap Other Inventory
OtherInventory
1551676 usd
CY2021Q4 us-gaap Other Inventory
OtherInventory
1269056 usd
CY2022Q3 us-gaap Other Inventory In Transit
OtherInventoryInTransit
235000 usd
CY2021Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
0 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
378234 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
443497 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1408442 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
825559 usd
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
244255 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
242131 usd
CY2022Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
35087 usd
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
16634 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
40584 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
46650 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
302896 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
276722 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
898538 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
718721 usd
CY2022Q3 us-gaap Investments And Cash
InvestmentsAndCash
2000000 usd
TKOI Debt Instrument Decrease Forgiveness Including Interest
DebtInstrumentDecreaseForgivenessIncludingInterest
1836780 usd
CY2009Q4 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
1628800 usd
CY2009Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.33
CY2009Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
13774 shares
CY2009Q4 us-gaap Shares Issued
SharesIssued
1075000 shares
CY2010Q3 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
38461 shares
CY2010Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.13
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
5211542 usd
us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
38461 shares
CY2010Q3 us-gaap Preferred Stock Dividends Shares
PreferredStockDividendsShares
486 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1815 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1815 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5445 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5446 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
75880 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
87600 usd
us-gaap Lease Cost
LeaseCost
235188 usd
us-gaap Lease Cost
LeaseCost
263849 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
49947 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
57387 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
146236 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
172161 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
25933 usd
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
30213 usd
us-gaap Variable Lease Cost
VariableLeaseCost
88952 usd
us-gaap Variable Lease Cost
VariableLeaseCost
91688 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
153276 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
195176 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
391680 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
459668 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
109888 usd
CY2021 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
242305 usd
CY2021 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
92666 usd
CY2022Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
35087 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
47771 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
193169 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
172424 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
158510 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
53185 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
625059 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
80103 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
544956 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
75880 usd
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
87600 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
235188 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
263849 usd
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
25000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
196724 usd
CY2022Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
56724 usd
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
140000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
255000 usd
CY2021Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
16634 usd
CY2020Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
31396 usd
TKOI Sales Tax Collected
SalesTaxCollected
122460 usd
CY2021 TKOI Sales Tax Collected
SalesTaxCollected
85589 usd
TKOI Provisions Reversals Of Sales Tax
ProvisionsReversalsOfSalesTax
8231 usd
CY2021 TKOI Provisions Reversals Of Sales Tax
ProvisionsReversalsOfSalesTax
-7685 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
112238 usd
CY2021Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
16634 usd
CY2022Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
46000 usd
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
134000 usd

Files In Submission

Name View Source Status
0001683168-22-007604-index-headers.html Edgar Link pending
0001683168-22-007604-index.html Edgar Link pending
0001683168-22-007604.txt Edgar Link pending
0001683168-22-007604-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tkoi-20220930_cal.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
telkonet_3101.htm Edgar Link pending
telkonet_3102.htm Edgar Link pending
telkonet_3201.htm Edgar Link pending
telkonet_3202.htm Edgar Link pending
telkonet_i10q-093022.htm Edgar Link pending
tkoi-20220930.xsd Edgar Link pending
tkoi-20220930_pre.xml Edgar Link unprocessable
tkoi-20220930_def.xml Edgar Link unprocessable
tkoi-20220930_lab.xml Edgar Link unprocessable
telkonet_i10q-093022_htm.xml Edgar Link completed